NDC Pharmacologic Class N0000191730 PCSK9 Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0024-5901Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5902Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5903Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5904Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
55513-750Repatha EvolocumabInjection, SolutionSubcutaneousAmgen IncHuman Prescription Drug
55513-760Repatha EvolocumabInjection, SolutionSubcutaneousAmgen IncHuman Prescription Drug
72511-750Repatha EvolocumabInjection, SolutionSubcutaneousAmgen Usa Inc.Human Prescription Drug
72511-760Repatha EvolocumabInjection, SolutionSubcutaneousAmgen Usa Inc.Human Prescription Drug
72733-5901Praluent AlirocumabInjection, SolutionSubcutaneousSanofi Us CorporationHuman Prescription Drug
72733-5902Praluent AlirocumabInjection, SolutionSubcutaneousSanofi Us CorporationHuman Prescription Drug

There are 10 NDC products with the pharmacologic class PCSK9 Inhibitors [MoA].